A shadow market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Experimental Drug Gaining Traction Via Social Media
Retatrutide, which remains in clinical trials, is being advertised by online personalities for its supposed weight-reducing properties. Viewers are encouraged to message these accounts directly for supplier links, while also obtaining discount codes.
Active Trade on Messaging Platforms
Additionally, a robust market exists on Telegram, where groups with thousands of members share comparison images, injection guides and claims of rapid UK delivery. Sellers promote the drug there before redirecting buyers to other platforms for transactions.
Learning About The Experimental Drug
This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.
Medical Experts Voice Worries
However, doctors and chemists have cautions that the distribution of what remains an unapproved drug in the UK is a cause for concern and could lead to individuals injecting substances of uncertain source.
Some experts stated the popularity for retatrutide could be linked to the increasing price of licensed slimming treatments such as Mounjaro.
Legal Status and Enforcement
Marketing retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unapproved drug that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Several influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still violate pharmaceutical, marketing, and customer regulations, potentially leading to penalties, legal action or imprisonment.
Service Reaction and Material Removal
According to TikTok, the platform has removed violative content and prohibited related keywords and query recommendations. The organization said it was dedicated to keeping the platform safe and allocating resources in strengthening enforcement strategies.
Online Trading Activities
Investigations also found communities with up to 9,000 participants marketing retatrutide using Telegram's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” instantly brings up channels with numerous of members, populated with images of weight loss, glowing testimonials and detailed instructions for mixing or injecting at residence.
After moments of joining one group, a seller shared contact information, where the majority of transactions take place. The vendor provided an guidebook and guaranteed shipping within 48 hours. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one asked about weight, medical conditions or previous experience.
Product Information and Costs
Within these communities, messages display black plastic parcels with Royal Mail stickers, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use pens usually sold at £160 for 20mg. When asked how long a injector should last, sellers give contradictory responses varying between a few weeks to “depends on your body”.
Platform Moderation and Safety Measures
A spokesperson for Telegram said it regularly moderated dangerous material on its platform including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are injecting materials they can’t verify. Although the research behind this drug is valid, these digital products may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to recent price rises for approved slimming medications such as Mounjaro. “With prices increasing, patients are turning to online platforms. But fake treatments are highly risky. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she said.
Her staff has previously seen patients injured by personal administration from unconfirmed sources. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” stated the doctor. “These substances could be impure or incorrectly dosed.”
Producer Statement
A spokesperson from Eli Lilly said the substance was in phase 3 clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, adding that any product “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may subject patients to possibly significant medical dangers”.
